Imaging biomarkers : dopaminergic transporter (DaT) SPECT, PET tracers for -synuclein
Di Micco, R., Krizhanovsky, V., Baker, D
this may be due to the nature of the condition or via the limitation of therapeutic options available to these patients [7,8,9,10,11,12]
This change not only offers convenience but also broadens the accessibility of these medications, potentially benefiting many managing type 2 diabetes
Our meals are crafted to be protein-rich, nutrient-dense, and easy to digest, making them the ideal choice for anyone on a GLP-1 weight-loss or diabetes-management journey
[3] [4] Because retatrutide is unlicensed, it may only be supplied to a patient in the UK on a named-patient basis a route known as an unlicensed 'Special' where a registered prescriber takes personal responsibility for its use, confirms that no suitable licensed alternative exists, and ensures the patient is fully informed of its unlicensed status